Drug Resistance in Cancer Cells - Image 1

£107.73

Springer Drug Resistance in Cancer Cells

Name: Drug Resistance in Cancer Cells
Brand: Springer
Price: 107.27 GBP
Availability: InStock

Oncology

Price History & Forecast

Last 74 days • 74 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 74 days • 1 price levels

Days at Price

Price Analysis

Most common price: £107 (74 days, 100.0%)

Price range: £107 - £107

Price levels: 1 different prices over 74 days

Description

Product Description The inability of cancer drugs to destroy metastatic tumors is the main reason cancer therapy fails. This comprehensive text offers current knowledge on genetic and epigenetic alterations that contribute to the development of drug resistance in cancer cells. From the Back Cover An estimated 1.5 million patients in the United States are diagnosed with cancer every year and over half-a-million individuals die of the disease. Since the vast majority of the deaths occur after medical intervention with anticancer therapy, both conventional chemotherapy and novel targeted therapy, it can be concluded that these patients die from drug resistant cancers. A growing number of studies have revealed that mechanisms underlying the development of drug resistance in cancer cells are manifold and complex and very likely are dependent on cell and microenvironment context. In view of these facts, it is important to document the mechanisms of drug resistance and understand which are the dominant resistance pathways in a particular tumor type that could provide potential therapeutic targets in a clinical setting. This book serves as a single source for the current knowledge on genetic and epigenetic alterations that contribute to the development of drug resistance. Comprehensive reviews written by renowned experts provide great insight on the current knowledge on drug resistance mechanisms. This book is a ready source of information to clinicians, cell and cancer biologists and defines molecular drug resistance mechanisms that are challenging scientists and clinical oncologists today.About Editors:Dr. Kapil Mehta is a Professor in the Department of Experimental Therapeutics, The University of Texas M. D Anderson Cancer Center, Houston, TX. He has published widely and received several patents on novel discoveries relating to drug resistance in the field of cancer therapeutics. Dr. Zahid H. Siddik is also a Professor in the Department of Experimental Therapeutics at The University of Texas M.D. Anderson Cancer Center. He has studied extensively the mechanisms of drug action and resistance, and is recognized for his seminal studies with platinum-based antitumor agents.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 1441927948
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 29 October 2010
Listed Since: 20 December 2010

Barcode

No barcode data available

Springer Drug Resistance in Cancer Cells

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Cancer Drug Resistance (Cancer Drug Discovery and Development)

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Drug Resistant Neoplasms (Cancer Etiology Diagnosis and Treatment Series)

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Multi-Drug Resistance in Cancer: 596 (Methods in Molecular Biology, 596)

Multi-Drug Resistance in Cancer: 596 (Methods in Molecular Biology, 596)

Breast Cancer Metastasis and Drug Resistance: Challenges and Progress: 1152 (Advances in Experimental Medicine and Biology, 1152)

Anticancer Drug Resistance: Advances in Molecular and Clinical Research: 73 (Cancer Treatment and Research, 73)

Progress in Cancer Drug Resistance Research

Cancer Drug Resistance (Cancer Drug Discovery and Development)

Molecular Oncology: Underlying Mechanisms and Translational Advancements

CRC Press Rediscovering Cancer: From Mechanism to Therapy

Springer - Therapeutic Resistance to Anti-hormonal Drugs Book

Cytotoxic Drug Resistance Mechanisms: 28 (Methods in Molecular Medicine, 28)

Rediscovering Cancer: From Mechanism to Therapy

Cancer Cell Chemoresistance And Chemosensitization

Targeted Therapies: Mechanisms of Resistance (Molecular and Translational Medicine)

Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)

Springer - Molecular Mechanisms of Tumor Cell Resistance

Resistance to Targeted ABC Transporters in Cancer: 4 (Resistance to Targeted Anti-Cancer Therapeutics)

Genomic Instability and Cancer Metastasis: Mechanisms, Emerging Themes, and Novel Therapeutic Strategies: 20 (Cancer Metastasis - Biology and Treatment, 20)

Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance (Volume 12) (Cancer Sensitizing Agents for Chemotherapy, Volume 12)

Cancer Stem Cell Resistance to Targeted Therapy: 19 (Resistance to Targeted Anti-Cancer Therapeutics, 19)

Targeted Therapies: Mechanisms of Resistance (Molecular and Translational Medicine)